Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman Provided by GlobeNewswire Aug 20, 2025, 10:16:11 AM ...

This Mike Judge series failed to create compelling characters and effective satire about liberals.

Replimune (REPL) stock plummets as report suggests FDA’s top regulator of cancer drugs intervened in rejecting its lead asset. Read more here.

REPL CLASS ACTION ALERT: FDA Response Letter Leads to Replimune Group, Inc. Class Action – Investors are Notified to Contact BFA Law by September 22 Deadline ...

It is one of the biggest jobs in youth football but what is required of the person to take over United's academy?

Trump on strike of Iranian nuclear site: ‘I may do it. I may not do it.’ The president said he recently spoke with Iranian leaders who floated a visit to the White House amid ongoing conflict.

Notable Monday Option Activity: VERA, REPL, CLF June 02, 2025 — 03:27 pm EDT Written by BNK Invest for BNK Invest -> ...

Striking junior doctors no longer have public’s backing, Wes Streeting says The health secretary’s intervention marks a drastic shift in tone after he brought months of strike action to an end ...

Replimune Group Inc (REPL) anticipates RP1's potential approval and launch, while navigating increased expenses and a significant net loss.

Spies hack high-value mail servers using an exploit from yesteryear Attacks spilled contacts and emails from targeted accounts.